Unexpected high levels of multidrug-resistant tuberculosis present new challenges for tuberculosis control

The Lancet

Volumn 380, Issue 9851, 2012, Pages 1367-1369

  Hoffner, Sven ^a  

^a SWEDISH INSTITUTE FOR INFECTIOUS DISEASE CONTROL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

PYRAZINAMIDE; QUINOLONE DERIVATIVE;

COMORBIDITY; DRUG SENSITIVITY; DRUG USE; ESTONIA; EXTENSIVELY DRUG RESISTANT TUBERCULOSIS; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; LATVIA; MULTIDRUG RESISTANT TUBERCULOSIS; MYCOBACTERIUM TUBERCULOSIS; NOTE; PERU; PHILIPPINES; PREVALENCE; PRIORITY JOURNAL; QUALITY CONTROL; RUSSIAN FEDERATION; SOUTH AFRICA; SOUTH KOREA; TAIWAN; THAILAND; TUBERCULOSIS CONTROL;

EID: 84867742983     PISSN: 01406736     EISSN: 1474547X     Source Type: Journal    
DOI: 10.1016/S0140-6736(12)61069-1     Document Type: Note

References (13)

1. A Skrahina, H Hurevich, A Zalutskaya et al. Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk Eur Respir J 39 2012 1425 1431
2. T Dalton, P Cegielski, S Akksilp and the Global PETTS Investigators Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective study Lancet 2012 http://dx.doi.org/10.1016/S0140-6736(12)60734-X published online Aug 30.
3. A Kruuner, SE Hoffner, H Sillastu et al. Spread of drug-resistant pulmonary tuberculosis in Estonia J Clin Microbiol 39 2001 3339 3345
4. A Nodieva, I Jansone, L Broka, I Pole, G Skenders, V Baumanis Recent nosocomial transmission and genotypes of multidrug-resistant Mycobacterium tuberculosis Int J Tuberc Lung Dis 14 2010 427 433
5. WHO Anti-tuberculosis drug resistance in the world, report no. 4: The WHO/IUALTD Global Project on Anti-tuberculosis Drug Resistance Surveillance 2002-2007 2008 World Health Organization Geneva
6. M Zignol, W van Gemert, D Falzon et al. Surveillance of anti-tuberculosis drug resistance in the world: An updated analysis, 2007-2010 Bull World Health Organ 90 2012 111 119
7. A Wright, M Zignol, A Van Deun for the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Epidemiology of antituberculosis drug resistance 2002-07: an updated analysis of the Global Project on Anti-Tuberculosis Drug Resistance Surveillance Lancet 373 2009 1861 1873
8. AA Velayati, MR Masjedi, P Farnia et al. Emergence of new forms of totally drug-resistant tuberculosis bacilli: super extensively drug-resistant tuberculosis or totally drug-resistant strains in Iran Chest 136 2009 420 425
9. ZF Udwadia, RA Amale, KK Ajbani, C Rodrigues Totally drug-resistant tuberculosis in India Clin Infect Dis 54 2012 579 581
10. O Ignatyeva, I Kontsevaya, A Kovalyov et al. Detection of resistance to second-line antituberculosis drugs by use of the genotype MTBDRsl assay: a multicenter evaluation and feasibility study J Clin Microbiol 50 2012 1593 1597
11. A Van Deun, A Wright, M Zignol, K Weyer, HL Rieder Drug susceptibility testing proficiency in the network of supranational tuberculosis reference laboratories Int J Tuberc Lung Dis 15 2011 116 124
12. AH Diacon, R Dawson, F von Groote-Bidlingmaier et al. 14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial Lancet 2012 http://dx.doi.org/10.1016/S0140-6736(12)61080-0 published online July 23.
13. KC Chang, WW Yew, Y Zhang Pyrazinamide susceptibility testing in Mycobacterium tuberculosis: a systematic review with meta-analyses Antimicrob Agents Chemother 55 2011 4499 4505